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Oxygen heterogeneity in solid tumors is recognized as a limit-
ing factor for therapeutic efficacy. This heterogeneity arises from
the abnormal vascular structure of the tumor, but the precise
mechanisms linking abnormal structure and compromised oxy-
gen transport are only partially understood. In this paper, we
investigate the role that red blood cell (RBC) transport plays in
establishing oxygen heterogeneity in tumor tissue. We focus on
heterogeneity driven by network effects, which are challenging
to observe experimentally due to the reduced fields of view
typically considered. Motivated by our findings of abnormal vas-
cular patterns linked to deviations from current RBC transport
theory, we calculated average vessel lengths L̄ and diameters
d̄ from tumor allografts of three cancer cell lines and observed
a substantial reduction in the ratio λ= L̄/d̄ compared to phys-
iological conditions. Mathematical modeling reveals that small
values of the ratio λ (i.e., λ< 6) can bias hematocrit distribu-
tion in tumor vascular networks and drive heterogeneous oxy-
genation of tumor tissue. Finally, we show an increase in the
value of λ in tumor vascular networks following treatment with
the antiangiogenic cancer agent DC101. Based on our findings,
we propose λ as an effective way of monitoring the efficacy
of antiangiogenic agents and as a proxy measure of perfu-
sion and oxygenation in tumor tissue undergoing antiangiogenic
treatment.
tumor vasculature | hematocrit dynamics | oxygen heterogeneity |
anti-angiogenic agents | mathematical modelling
T issue oxygenation plays a crucial role in the growth andresponse to treatment of cancer. Indeed, well-oxygenated
tumor regions respond to radiotherapy better than hypoxic, or
oxygen-deficient, regions by a factor of up to three (1, 2). Fur-
ther, the increased rates of proteomic and genomic modifications
and clonal selection associated with anoxia (i.e., total oxygen
depletion) endow tumors with more aggressive and metastatic
phenotypes (3, 4). Oxygen heterogeneity in solid tumors is com-
monly attributed to their abnormal vasculature (5, 6). This link
is arguably multifactorial, including nonuniform vessel distribu-
tion, inefficient vessel organization (e.g., functional shunting),
flow fluctuations, and variations in red blood cell (RBC) flux
(see ref. 7 for a review). However, the dynamics of abnormal oxy-
gen transport at the whole vascular-network level have not been
addressed.
Oxygen is transported through the vasculature by binding to
hemoglobin in RBCs (8). Hematocrit, or the volume fraction of
RBCs in whole blood, does not distribute uniformly throughout
the vasculature (9, 10). At a bifurcation with one afferent and two
efferent branches, it is typically assumed that the efferent branch
with the highest flow rate will have the highest discharge hema-
tocrit (10, 11) due to, among other features, plasma skimming
(PS) caused by the presence of an RBC-depleted layer, or cell-
free layer (CFL) (12). In addition, confinement effects can lead
to further reduction of the tube hematocrit compared to the dis-
charge value. In this study, we will refer to discharge hematocrit
only. How abnormal tumor vascularization impacts hematocrit
splitting (HS) at bifurcations and the potential network effects
arising have not been addressed.
Significance
Oxygen heterogeneity in solid tumors is recognized as a lim-
iting factor for therapeutic efficacy. This heterogeneity arises
from the abnormal tumor vascular structure. We investigate
the role that anomalies in red blood cell transport plays in
establishing oxygen heterogeneity in tumor tissue. We intro-
duce a metric to characterize tumor vasculature (mean vessel
length-to-diameter ratio, λ) and demonstrate how it predicts
tissue-oxygen heterogeneity. We also report an increase in
λ following treatment with the antiangiogenic agent DC101.
Together, we propose λ as an effective way of monitoring
the action of antiangiogenic agents and a proxy measure of
oxygen heterogeneity in tumor tissue. Unraveling the causal
relationship between tumor vascular structure and tissue oxy-
genation will pave the way for new personalized therapeutic
approaches.
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N.D. performed research; M.O.B., J. Köry, J.A.G., B.M., A.B., M.d., R.E., J. Kaeppler, N.D.,
J.H., T.K., and J.M.P.-F. contributed new reagents/analytic tools; M.O.B., J. Köry, J.A.G.,
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In this paper, we investigate the role that anomalies in RBC
transport play on establishing oxygen heterogeneity in tumor
tissue. We focus on heterogeneity driven by network effects,
which are difficult to resolve experimentally due to the reduced
fields of view typically considered. Live imaging of tumor allo-
grafts of three cancer cell lines reveals abnormal morpholog-
ical vascular patterns, such as short interbifurcation distances
and complex topological configurations. Furthermore, detailed
numerical simulations describing the transport of RBCs predict
deviations from current HS theory in these scenarios. When we
extract average vessel lengths L̄ and diameters d̄ from tumor
allografts of three cancer cell lines, we observe a substantial
reduction in the ratio λ= L̄/d̄ , an accepted parameter govern-
ing CFL dynamics, compared to physiological conditions. In
addition, our RBC simulations reveal 1) asymmetric CFL width
disruption following a bifurcation; and 2) that the average mea-
sured λ value in tumor allografts is too small for the CFL to
recover full symmetry between consecutive branching points,
leading to uneven hematocrit split in the downstream branch-
ing point.
Based on the RBC simulations, we propose an HS rule
that accounts for CFL disruption due to pathologically small
λ values. We integrate this rule into existing models of tumor
blood flow and oxygen transport (13) and observe a hemat-
ocrit memory effect leading to hemoconcentration/hemodilution
in densely branched vessel networks. As a consequence, the
predicted tissue oxygenation is highly heterogeneous and dif-
fers markedly from predictions generated by using rules for HS
under physiological conditions (e.g., refs. 5 and 14–17). These
findings provide a mechanistic explanation for previous reports
of hemoconcentration/hemodilution in tumor vasculature (18),
plasma flow (19), and well-perfused vessels that are hypoxic
(20). Furthermore, previous work has demonstrated that fluctu-
ations in RBC flux in the tumor microvasculature are associated
with instabilities in oxygen concentration in the extravascu-
lar space (21, 22). However, the mechanism underlying these
fluctuations remains unclear. Our findings of hematocrit net-
work effects support the hypothesis that vascular structural
instability (associated with vascular remodeling or angiogene-
sis) can induce long-range changes in RBC flux throughout the
network.
Finally, we demonstrate the preclinical relevance of our find-
ings by showing an increase in the average λ value of tumor
vascular networks following treatment with the DC101 antian-
giogenic cancer agent. Based on our results, we propose λ as an
effective way of monitoring the action of antiangiogenic agents
and as a proxy measure of oxygen heterogeneity in tumor tis-
sue undergoing antiangiogenic treatment. Future experimental
studies should confirm this finding and elucidate its relative
importance compared to well-characterized mechanisms of nor-
malization [e.g., permeability reduction or vessel decompress-
ion (23)].
Results
Average Distance between Vessel Branch Points Is Shorter in Solid
Tumors than in Healthy Tissue. We implemented a protocol for in
vivo imaging of tumor vasculature (24) and exploited our recently
published methods for vessel segmentation (25, 26) and three-
dimensional (3D) vascular network reconstruction to character-
ize the morphology of tumor vasculature. Most analyses of tumor
vasculature are based on histological sections that give only par-
tial information about the 3D structure of the entire network.
Vascular casts (see ref. 27 for a review) and optical clearance
techniques (28) have been used successfully to image the com-
plete tumor vasculature, but they provide information at only one
time point. Further, information about vessel perfusion and/or
the physiological pressures that drive blood flow are not avail-
able. By applying intravital video microscopy to mice in which all
of the endothelium is fluorescent, it was possible to image the
entire tumor vasculature: Individual vessels could be detected,
regardless of their level of perfusion (see Materials and Methods
for more details). Briefly, tumor allografts of three murine cancer
cell lines (i.e., MC38, colorectal carcinoma; B16F10, melanoma;
and LLC, Lewis lung carcinoma) were implanted in mice, con-
trolled for size, and imaged through an abdominal window
chamber by using a multiphoton microscope over multiple days.
The vascular networks in the 3D image stacks were segmented,
and the associated network skeletons and vessel diameters were
computed (25, 26). Flow direction was determined by tracking
the movement of fluorescently labeled RBCs. Upon inspection,
the segmented vascular networks presented abnormal morpho-
logical vascular patterns, such as short interbifurcation distances,
and complex topological configurations, such as three- to two-
branch mergers (Fig. 1 A and B). Motivated by these findings,
we exploited recent advances in blood-flow simulation methods
by our group and others (29–32) to investigate the link between
these abnormal patterns and RBC transport. A computational
model of liquid-filled deformable particles (discocytes approx-
imating the shape of an RBC) suspended in an ambient fluid
was used to simulate blood flow in a subset of the network, with
RBCs inserted at the network inlet and removed at the outlets
(see Materials and Methods and SI Appendix for more details).
Our simulations demonstrate that reduced interbifurcation dis-
tance can lead to an inversion of HS, as predicted by existing
theory (11), where the branch with highest flow receives pro-
portionally fewer RBCs and vice versa (Fig. 1 C and D). In
addition, the same effect is highly attenuated in the complex
topology case.
We then asked how prevalent these abnormal vasculariza-
tion patterns are throughout the tumor networks imaged. Fig. 2
A and B shows the two-dimensional (2D) maximum projec-
tion of an example dataset, along with a 2D projection of its
segmentation and a close-in overlaying segmentation and skele-
tonization. Vessel lengths (L) and diameters (d) in the networks
followed a right-skewed distribution resembling a log-normal
distribution (Fig. 2 C–E and Datasets S1–S3). No correla-
tion was found between the variables (Pearson’s r2< 0.04 for
all samples analyzed; Fig. 2 C–E and SI Appendix, Tables S4
and S5).
Table 1 summarizes last-day statistics for all of the experi-
ments and averages per cell line. In the example MC38 dataset
from Fig. 2A, average vessel length (L̄) and diameter (d̄) were
143 and 45.5 µm, respectively. We observed how the group aver-
age vessel length was 128.6, 125.9, and 108.8 µm for MC38,
B16F10, and LLC, respectively. The average diameters were
33, 36.5, and 35.7 µm, respectively, which is within the range
described for tumor vasculature (33). In addition, the length-
to-diameter ratios (λ) are 4.0, 3.4, 3.0, respectively, which is
substantially smaller than typical λ values reported under physi-
ological conditions in a variety of tissues (SI Appendix, Table S1)
and representative of the high branching density encountered
in tumor vasculature (34) and in line with the observation
in Fig. 1B.
PS in Tumor-Like Vasculature Is Biased by History Effects Arising from
CFL Dynamics. Our finding of reduced interbranching point dis-
tance in tumor tissue motivated us to investigate a potential
causal relationship between the reduction in L and λ and the
profoundly abnormal tumor hemodynamics and mass transport
patterns described in the literature (35). Of particular inter-
est was establishing whether hemorheological phenomena may
contribute to tumor heterogeneity and hypoxia.
The presence of an RBC-depleted region adjacent to the ves-
sel walls (i.e., the CFL) is a key contributor to PS (10–12).
Previous studies have shown CFL disruption after microvascular
27812 | www.pnas.org/cgi/doi/10.1073/pnas.2007770117 Bernabeu et al.
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Fig. 1. (A) Multiphoton image (0.83 µm × 0.83 µm × 3 µm resolution) of a MC38 tumor vessel network obtained via an abdominal imaging window
in mouse. Red, endothelial cells; green, tumor cells. White box shows region of interest. (Scale bar, 100 µm.) (B) Region of interest showing endothelial
cell-staining channel alone. Abnormal vascular morphology: reduced interbifurcation distance (between arrowheads) and complex topology (three- to two-
branch merger, star). Arrows indicate direction of flow. (Scale bar, 50 µm.) (C) RBC flow simulation in realistic network with vessel identities in computational
domain reconstructed from region of interest. (D) RBC flow-simulation analysis. RBC enrichment/depletion after branching point. Solid line represents
proportional partitioning based on flow rates. Existing PS theory predicts enrichment in higher-flow branch. RBC simulations (Sim) show inversion of effect
in reduced interbifurcation case and strong attention in complex topology case. PS theory refers to ref. 11.
bifurcations and found that the length required for CFL recov-
ery, lr , is in the region of 10 vessel diameters (d) for d <
40 µm (11), 8 to 15d for d ∈ [20, 24]µm (36), and 25d for
d ∈ [10, 100]µm (37). These values are substantially higher than
the average λ values given in Table 1, λ< lr , and, there-
fore, we expect that, on average, CFL symmetry will not
recover between the branching points in the networks under
study.
Motivated by these findings, we applied our RBC simulation
approach to investigate the link between CFL dynamics and PS
in a tumor-inspired 3D microvascular network. Our intention
was to understand the extent to which CFL disruption effects
arising at a bifurcation affect HS in downstream bifurcations
for small interbifurcation distances relevant to tumor vascula-
ture (see Materials and Methods for further details). Briefly, we
defined a set of networks of 3D cylindrical channels of con-
stant radius, consisting of one main channel with an inlet and
an outlet and two side branches, which defined two consecutive
bifurcations (Fig. 3). We considered interbifurcation distances
of 4 and 25 channel diameters based on our tumor vascular
network analysis and the largest of the CFL recovery distances
reviewed earlier. We positioned the two side branches on the
same side of the main channel or on opposite sides. Flow rates
at the network inlet and outlets were configured such that at
each bifurcation, flow was split evenly. We performed blood-
flow simulations (three runs in each network, with random
perturbations in the RBC insertion procedure), and, after the
initial transient time required to fully populate the network with
RBCs, we quantified discharge hematocrit by an RBC-counting
procedure.
Fig. 3 A and B and Table 2 show how hematocrit split is close
to even at bifurcation 1 for all geometries studied, as would be
predicted by existing theoretical models of HS. However, dif-
ferent degrees of HS occur at bifurcation 2. In the double-t
geometry, we observed hemodilution in branch 3 and hemo-
concentration in branch 4 (16.8% vs. 23%, P < 0.001; Fig. 3B),
which we will refer to as the unfavorable and favorable branches.
These effects are not statistically significant in the same branches
in the extended double-t geometry (19.1% vs. 19.4%, P = 0.3;
Fig. 3A). The hemoconcentration/hemodilution effect is present
in the cross geometry, but the branches experiencing it are
interchanged (22.1% vs. 17.1%, P < 0.001; Fig. 3C). In contrast
with these results, existing HS theoretical models would pre-
dict even HS at bifurcation 2, regardless of the interbifurcation
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Fig. 2. (A) Maximum intensity projection of multiphoton image stack of a tumor vessel network obtained via an abdominal imaging window in mouse
from the MC38 dataset. Red, perfusion; cyan, endothelial cells; green, GFP tumor cells. (Scale bars: 1 mm.) (B) The stack is subsequently segmented and
skeletonized, and distributions of vessel diameters and lengths are calculated. Red, vascular network segmentation; dark, skeletonization. Mouse MC38-5
in Table 1. (C–E) Scatter plots of vessel lengths vs. diameters for different cell lines studied: MC38 (mouse 3 in Table 1) (C), B16F10 (mouse 1 in Table 1) (D),
and LLC (mouse 1 in Table 1) (E).
distance, due to the prescribed symmetrical flow and geometry
conditions.
On closer inspection, the dynamics of the CFL show how,
after bifurcation 1, CFL width is initially negligible and rapidly
increases on the side of channel 1, leading to the favorable
branch (θ= 0; Fig. 3F). Conversely, CFL width increased after
the bifurcation and followed a downward trend in the oppo-
site side (θ=π; Fig. 3F). An interbifurcation distance of four
diameters is too short for the CFL width to equalize on both
sides (Fig. 3F). In contrast, CFL width has time to become
symmetric on both sides for an interbifurcation distance of 25
diameters (Fig. 3G).
Taken together, these results show how CFL asymmetry can
cause uneven hematocrit split in bifurcation 2 (Fig. 3E), irre-
spective of branching side—i.e., cross vs. double-t geometry.
Our results are consistent with the findings by Pries et al. (11),
describing how asymmetry of the hematocrit profile in the feed-
ing vessel of a bifurcation has a significant influence on RBC
distribution in the child vessels. In addition, we provide quan-
titative evidence of how CFL asymmetry may be the main
contributing factor.
Interestingly, we observed small, but statistically significant,
asymmetries in the hematocrit split in bifurcation 1 in the
extended double-t geometry (19.2% vs. 20.8%, P < 0.001;
Fig. 3A) and cross geometry (19.7% vs. 20.4%, P = 0.035;
Fig. 3C), which consistently favored the side branch. We attribute
this secondary effect to an asymmetrical streamline split in the
chosen geometry, as investigated in ref. 38.
We note that the effects described above depend on the angle
between the planes containing the two consecutive bifurcations.
Our data suggest that for angles of π
2
radian, the asymmet-
ric hematocrit split effects will not be observed since the CFL
width at π
2
and 3π
2
remained mostly symmetric (SI Appendix,
Fig. S2).
Table 1. Mean branch lengths (L̄), mean vessel diameters (d̄), and length-to-diameter ratio
(λ= L̄
d̄
=
∑
Li∑
di
) measured over all of the imaged vessels in tumor allografts from three murine cancer
cell lines
Cell line MC38 B16F10 LLC
Mouse 1 2 3 4 5 6 Av. 1 2 3 Av. 1
L̄,µm 123.9 129.9 143 112.4 132.1 130.0 128.6 123.2 123.5 131.0 125.9 108.8
d̄,µm 29.3 33.0 45.5 23.9 28.9 37.5 33.0 33.9 34.1 41.6 36.5 35.7
λ= L̄/d̄ 4.2 3.9 3.1 4.7 4.6 3.4 4.0 3.6 3.6 3.1 3.4 3.0
See SI Appendix, Tables S4 and S5 for correlation between variables. Av., average.
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Fig. 3. (A–C) Discharge hematocrit at different geometry branches: extended double-t geometry (A), double-t geometry (B), and cross geometry (C). (D)
Example simulated RBCs in the double-t geometry: The vessel network is rendered semitransparent in gray, and the RBC membranes are rendered in red
suspended in transparent blood plasma. (E) Schematic describing the impact of CFL dynamics on hematocrit split. (F and G) CFL width in opposite sides of
channel 1: double-t geometry (F) and extended double-t geometry (G).
Hematocrit History Effects Lead to Highly Heterogeneous Oxygen
Distributions in Solid Tumors. Existing theoretical models of HS
(11, 39–41) do not capture the hemoconcentration/hemodilution
effects in realistic and idealized vascular networks presented in
Figs. 1 and 3. We hypothesize that this is because they neglect
CFL disruption at bifurcations and its impact on subsequent
bifurcations. We propose an HS model which accounts for CFL
dynamics and show that it predicts history effects in dense
networks (see Materials and Methods for details and SI Appendix
for a description of its validation). The model is significantly less
computationally intensive to solve than the RBC simulations (see
Materials and Methods for details).
We used Murray’s law (42) and our experimentally measured
values of λ to design a synthetic vessel network comprising
consecutive double-t/cross bifurcations (see SI Appendix, Fig.
S4A and Materials and Methods for details). Most notably, at
all bifurcations, the flow split and the radii of the child ves-
sels were equal, a scenario where existing HS models would
predict homogeneous hematocrit throughout the network. We
simulated network blood flow using a Poiseuille flow approx-
imation with an HS model originally proposed by Pries et al.
(11, 39) (without memory effects) and our model (accounting
for memory effects). As for the RBC simulations, differences in
hematocrit between child branches emerged after two bifurca-
tions (SI Appendix, Fig. S4C) and were amplified with increasing
vessel-generation number (SI Appendix, Fig. S4D).
Our model predicts the emergence of a compensatory mech-
anism in child branches. Increased flow resistance in the branch
experiencing hemoconcentration led to partial rerouting of flow
in the other branch (SI Appendix, Fig. S4B). This, in turn, atten-
uated the hemoconcentration/hemodilution effects previously
described due to HS dependence on flow ratios.
We now consider how this memory effect in the hematocrit
distribution may affect oxygen distribution in the tissue being
perfused by the synthetic network. Following ref. 13 (see Mate-
rials and Methods for a description of the coupled model), the
hematocrit distribution in the network acts as a distributed
source term in a reaction–diffusion equation for tissue oxygen.
Table 2. Discharge hematocrit calculated at the different
branches of each bifurcation for the extended double-t (EDT)
geometry, double-t (DT) geometry, and cross (X) geometry
Branch 0 Branch 1 Branch 2
Bifurcation 1
EDT 20.06 (0.03) 19.23 (0.14) 20.80 (0.10)
DT 20.08 (0.06) 19.96 (0.19) 20.26 (0.05)
X 20.06 (0.02) 19.67 (0.09) 20.35 (0.20)
Bifurcation 2
EDT 19.23 (0.14) 19.05 (0.22) 19.4 (0.23)
DT 19.96 (0.19) 16.83 (0.24) 23.04 (0.46)
X 19.67 (0.09) 22.12 (0.26) 17.09 (0.13)
Values are given as mean (SE) over an ensemble of three simulations with
random perturbations in the RBC insertion procedure while the hematocrit
at the inlet is held constant.
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Fig. 4. (A and B) For λ= 4.0, the model with memory effects yields more
pronounced oxygen heterogeneity than previous theory (11) predicts (i.e.
more dispersed oxygen distribution) in A (model without memory effects)
and B (model with memory effects) (spatial scales are in micrometers; vessels
are shown in black for reference). (C) Violin plots show oxygen distributions
for varying λ and the two HS models under consideration. Heterogeneity
increases with λ for the model without memory effects, as expected, but the
model with memory effects predicts increased heterogeneity for very low λ.
The horizontal lines in oxygen distributions in C represent 25th, 50th, and
75th percentiles.
We defined sink terms so that oxygen was consumed at a con-
stant rate everywhere within the tissue. The equation was solved
numerically, and oxygen distributions generated by using two HS
models (with and without memory effects; SI Appendix, Fig. S5 A
and B) were compared for a range of λ values. We focused on the
central portion of the network (Fig. 4 A and B), where the tissue
was densely vascularized. The results presented in Fig. 4C and SI
Appendix, Fig. S6 show that for larger values of λ, the differences
in the oxygen distribution in the tissue for the two HS models are
not statistically significant (e.g., with λ= 10, P = 0.14). However,
as λ decreases, statistically significant differences appear (e.g.,
with λ= 4, P < 0.001). Without memory effects, the oxygen dis-
tributions become narrower as λ decreases; with memory effects,
the oxygen distributions are increasingly wider for λ< 10 (SI
Appendix, Fig. S6C), leading to higher dispersion in the distribu-
tions for small λ. This is indicative of much more heterogeneous
tissue oxygenation.
In the current study, we did not consider other sources of
heterogeneity, such as anisotropic transport and heterogeneous
consumption of oxygen or other morphological abnormalities
in the vascular networks. We hypothesize that their interaction
with the hematocrit history effects reported here will further
accentuate tissue oxygen heterogeneity.
Vascular Normalization Therapies Increase λ Ratio in Tumors. Our
findings of reduced λ ratio in tumor vasculature and associ-
ated predictions of increased oxygen heterogeneity led us to
investigate whether existing vascular normalization thera-
pies modulate this parameter. Previous reports (SI Appendix,
Table S2) have extensively demonstrated in multiple animal
models that antiangiogenic treatment leads to reduction in
tumor-vessel diameters. In those studies that analyze vessel
length and diameter posttreatment, vessel length either remains
unchanged or decreases to a lesser extent than vessel diame-
ter. These findings indicate an increase in λ ratio posttreatment.
Furthermore, Kamoun et al. (43) also reported a reduction in
tumor hemoconcentration posttreatement, which suggests an in
vivo link between an increase in λ, hematocrit normalization, and
oxygen-transport homogenization.
We validated these results in our animal model by calculating
the λ ratio following DC101 treatment (see Materials and Meth-
ods for details). Our results indicated that in the first 2 d post-
treatment, λ increases significantly and then starts to decrease,
matching the control trend (Fig. 5A, SI Appendix, Table S3, and
Dataset S4). This change is explained by a linear increase in
vessel length immediately after treatment (absent in the control
group), which is compensated after 2 d by an increase at a higher
rate in vessel diameter (comparable to the control group) (SI
Appendix, Fig. S7), and associated with a decrease in bifurcation
density, as would be expected from impaired angiogenesis and
vessel pruning (Fig. 5B and SI Appendix, Fig. S7). Our results
also demonstrate that, for vessels with diameters less than 50
µm, the fraction of perfused vessels increases after DC101 treat-
ment, reaching a maximum of 63% relative increase compared
to control after 2 d, before decreasing to match the controls
after 3 d (Fig. 5C). We note that the proportion of vessels with
diameter less than 50 µm is identical between groups, regard-
less of perfusion (SI Appendix, Fig. S7). Interestingly, the time
window in which perfusion peaks coincides with the largest post-
treatment increase in λ. However, the structural changes persist
beyond this window, which would suggest that improvements in
oxygen-transport homogeneity can be independent of perfusion.
Discussion
Hypoxia compromises the response of many tumors to treat-
ments such as radiotherapy, chemotherapy, and immunotherapy.
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Fig. 5. Vascular phenotypes in MC38 tumors over time following DC101 treatment compared with control (n = 5). DC101 λ ratio raw data are given in
SI Appendix, Table S3. (A) λ ratio. (B) Bifurcation density. (C) Fraction of perfused vessels. Plots show mean (solid markers) and SE (error bars). t test for
statistical significance, *P< 0.05; **P< 0.01.
27816 | www.pnas.org/cgi/doi/10.1073/pnas.2007770117 Bernabeu et al.
D
ow
nl
oa
de
d 
by
 g
ue
st
 o
n 
N
ov
em
be
r 
11
, 2
02
0 
BI
O
PH
YS
IC
S
A
N
D
CO
M
PU
TA
TI
O
N
A
L
BI
O
LO
G
Y
M
ED
IC
A
L
SC
IE
N
CE
S
Dominant causative factors for hypoxia associated with the
structure and function of the tumor vasculature include ineffi-
cient vessel organization and inadequate flow regulation. Moti-
vated by morphological analyses of vascular networks from
different tumor types and detailed computer simulations of
RBC transport through realistic and synthetic networks, we have
proposed a rheological mechanism for tumor hypoxia.
We analyzed vascular networks from murine MC38, B16F10,
and LLC tumor allografts. Upon inspection, the segmented
vascular networks presented abnormal morphological patterns,
such as reduced interbifurcation distance and branching points
with topological configurations different from the typical diverg-
ing/converging bifurcations. Detailed computer simulations of
RBC transport uncovered a link between these morphological
anomalies and strong deviations from the current HS theory,
including inversion of HS [a phenomenon that had only been
observed in vitro (44, 45)]. For each vessel segment within each
network, we calculated the metric λ, which is the ratio of its
length and diameter and has been shown to control CFL dynam-
ics. Average λ values for the three tumor cell lines were similar
in magnitude (λ̄∈ [3, 4.2]) and severalfold smaller than values
from a range of healthy tissues (λ̄∈ [9.5, 70]). Our RBC sim-
ulations confirmed previous reports of transient alterations in
the CFL downstream of network bifurcations [e.g., asymmetries
in the cross-sectional hematocrit profile following a bifurcation
(46, 47) and the temporal dynamics governing its axisymme-
try recovery (37)]. Further, for the λ values measured in our
tumors and the capillary number considered in our simulations,
the CFL did not become symmetric between consecutive branch-
ing points. This bias is amplified across branching points and
drives hemoconcentration/hemodilution at the network level.
Based on these findings, we developed a rule for HS at vessel
bifurcations that accounts for CFL disruption due to abnormally
short vessel segments and validated it against our fully resolved
RBC simulations. We then used our existing oxygen-transport
model (13) to demonstrate that this hematocrit memory effect
can generate heterogeneous oxygen distributions in tissues per-
fused by highly branched vascular networks and that the network
metric λ controls the extent of this heterogeneity. Finally, we
reported an increase in the average λ value of tumor vascu-
lar networks following treatment with the DC101 antiangiogenic
cancer agent.
The implications of our findings are multiple. We have intro-
duced a simple metric to characterize tumor vasculature based
on the mean length-to-diameter ratio of vessel segments (λ)
and demonstrated how it controls oxygen heterogeneity in a
synthetic, densely vascularized tissue model. Our findings, of
structurally induced hemodilution in vascular networks with low
λ values, provide a mechanistic explanation for experimental
observations of hemodilution in tumor vascular networks (18),
plasma flow (19), and the existence of well-perfused vessels
that are hypoxic (20). Furthermore, these findings support the
hypothesis that vascular structural instability (associated with
vascular remodeling or angiogenesis) leads to the fluctuations in
RBC flux previously linked with cycling hypoxia (21, 22). We con-
clude that vessel perfusion is a poor surrogate for oxygenation in
tissue perfused by vascular networks with low λ values. Further,
predictions of tissue oxygenation based on diffusion-dominated
oxygen transport (e.g., refs. 5 and (14)–(17)) may be inaccurate
if they neglect heterogeneity in the hematocrit distribution of the
vessel network.
Finally, antiangiogenic drugs have been shown to generate
transient periods of heightened homogeneous tissue oxygena-
tion, due to improved restructuring and reduced permeability
of tumor vessels (48). This phenomenon, termed “vascular nor-
malization” (6), can correct the deficient transport capabilities
of tumor vasculature and homogenize drug and oxygen cov-
erage, and, thereby, improve radiotherapy and chemotherapy
effectiveness (2). Our results demonstrate an increase in the
average λ value of tumor vascular networks posttreatment with
antiangiogenic drugs and predict that this would lead to a
less heterogeneous hematocrit distribution and more uniform
intratumoral oxygenation potentially independent of perfusion.
Based on our findings, we propose λ as an effective way of
monitoring the action of antiangiogenic agents. Further exper-
imental work, quantifying hematocrit network dynamics before
and after antiangiogenic treatment, is needed to test this predic-
tion and elucidate its importance in comparison with established
mechanisms of normalization [e.g., permeability reduction, ves-
sel decompression (23)]. If confirmed, this finding would provide
a theoretical foundation for the development of therapeutic
approaches for the normalization of tumor oxygenation involv-
ing the administration of agents that target λ and, therefore,
homogenize hematocrit and tissue oxygenation.
Materials and Methods
Tumor Allograft Model and Abdominal Imaging Window Protocol. The abdom-
inal window chamber was surgically implanted in transgenic mice on
a C57Bl/6 background that had expression of red fluorescent protein
tdTomato only in endothelial cells. The murine colon adenocarcinoma
(MC38), murine melanoma (B16F10), and murine LLC tumors with expression
of green fluorescent protein (GFP) in the cytoplasm were induced by inject-
ing 5 µL of dense cell suspension in a 50/50 mixture of saline and Matrigel
(Corning). For DC101 treatment, mice bearing MC38 tumors were treated
with anti-mouse VEGFR2 antibody (clone DC101, 500 µg/dose, 27 mg/kg; Bio
Cell) injected intraperitoneally on the first and fourth day of imaging. Prior
to imaging, we intravenously injected 100 µL of Tracker 705 Vascular Labels
(Thermo Fisher Scientific), which is a blood-pool-based labeling agent, thus
allowing us to determine whether vessels were perfused or not.
The direction of blood flow in the vessels was determined by tracking
the movement of fluorescently labeled RBCs. RBCs were isolated from blood
taken from an anesthetized donor mouse via cardiac puncture. RBCs were
washed twice in phosphate-buffered saline (PBS) and then labeled with DiD
Cell-Labeling Solution (Thermo Fisher). The labeled RBCs were then washed
twice again, resuspended in 1 mL of PBS, and then 100 µL of the resus-
pended labeled RBCs was injected via a tail vein prior to imaging. Isoflurane
inhalation anesthesia was used throughout the imaging; mice were kept
on a heated stage and in a heated chamber, and their breathing rate was
monitored.
Tumor images were acquired with a Zeiss LSM 880 microscope (Carl
Zeiss AG), connected to a Mai-Tai tunable laser (Newport Spectra Physics).
We used an excitation wavelength of 940 nm, and the emitted light was
collected with Gallium Arsenide Phosphide detectors through a 524- to
546-nm bandpass filter for GFP and a 562.5- to 587.5-nm bandpass filter
for tdTomato and with a multialkali photomultiplier tube detector through
a 670- to 760-nm bandpass filter for Tracker 705 and DiD. A 20× water-
immersion objective with numerical aperture of 1.0 was used to acquire a
Zstacks-TileScan with dimensions of 512× 512 pixels in x and y and approx-
imately 70 planes in z. Voxel size was 3 to 5 µm in the z direction and
0.83 µm × 0.83 µm in the x–y plane. Each tumor was covered by approx-
imately 100 tiles. The morphological characteristics of tumor vasculature
were obtained from the acquired images as described (25, 26). All animal
studies were performed in accordance with the Animals Scientific Proce-
dures Act of 1986 (UK) and Committee on the Ethics of Animal Experiments
of the University of Oxford.
RBC Simulations in Realistic and Synthetic Capillary Networks. We created a
realistic network of tumor capillaries (SI Appendix, Fig. S1) based on the
images in Fig. 1 and a described protocol (49, 50). Flow direction at the
boundaries was assigned in agreement with experimental observations of
fluorescent RBC tracking. The inlets in the domain were connected together
to facilitate definition of flow and RBC boundary conditions (and similarly
with the outlets).
For our synthetic network simulations, we defined a set of networks of
cylindrical channels of diameter d. An inlet channel of length 25d (channel
0) bifurcated into two channels of length δ and 25d at π and π/2 radians
clockwise, respectively (channels 1 and 2). Channel 1 bifurcated into two
channels of length 25d at π andα radians clockwise, respectively (channels 3
and 4). We considered the following configurations (Fig. 3): double-t geom-
etry (δ= 4d,α=π/2), cross geometry (δ= 4d,α= 3π/2), and extended
double-t geometry (δ= 25d,α=π/2). Interbifurcation distance δ was
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calculated between the centerlines of channels 2 and 4 for consistency with
our experimental morphological characterization.
A model of liquid-filled elastic membranes (discocytes of 8-µm diameter
approximating the shape of an RBC) suspended in an ambient fluid was used
to simulate blood flow in the networks. We used the fluid-structure interac-
tion algorithm presented and validated by Krüger et al. (51), which is based
on coupling the lattice Boltzmann method (LBM), finite element method,
and immerse boundary method. The discocyte membranes were discretized
into 500 triangles, which imposed a voxel size of 0.8 µm on the regular grid
used in the LBM simulation. The mechanical properties of the membrane
were defined to achieve a capillary number (i.e., the ratio of viscous fluid
stress acting on the membrane and a characteristic elastic membrane stress)
of 0.1 in channel 0. The coupled algorithm is implemented in the HemeLB
blood flow simulation software (49, 52) (http://ccs.chem.ucl.ac.uk/hemelb).
Simulations ran on up to 456 cores of the ARCHER supercomputer, taking 11
to 32 h. See SI Appendix for full details.
A constant flow rate of Q0 = v̄inletπd
2/4 and a procedure for RBC inser-
tion with discharge hematocrit Hinlet was imposed at the network inlet. In
the synthetic networks, the outlet flow rates were set to Q2 = Q0/2 and
Q3,4 = Q0/4 to ensure an equal flow split at each bifurcation. RBCs were
removed from the computational domain when they reached the end of
any outlet channel. SI Appendix, Table S6 summarizes the key parameters
in the model. We performed blood-flow simulations (in the synthetic net-
works, three runs in each network, with random perturbations in the RBC
insertion procedure), and, after the initial transient required to fully popu-
late the network with RBCs, we quantified hematocrit by an RBC-counting
procedure.
Hybrid Model for Tissue Oxygen Perfusion that Accounts for History Effects
in Vascular Networks. We first explain how our vascular networks are
designed. Then, we describe how blood flow and hematocrit are
determined. Next, we introduce the HS models and explain how CFL mem-
ory effects are incorporated and the resulting flow problem solved. We
conclude by describing how the resulting hematocrit distribution is used to
calculate oxygen perfusion in the surrounding tissue. The basic steps of our
method are summarized in the flowchart in SI Appendix, Fig. S3.
Synthetic network design. Our networks have one inlet vessel (with
imposed blood pressure and hematocrit; we call this generation 0), which
splits into two child vessels (generation 1), which then split into two child
vessels (generation 2), and so on until a prescribed (finite) number of gen-
erations is reached. This defines a sequence of consecutive double-t/cross
bifurcations. Thereafter, the vessels converge symmetrically in pairs until
a single outlet vessel is obtained (with imposed blood pressure). At every
bifurcation, the diameters of the two child vessels are assumed to be equal
and determined by appealing to Murray’s law (42). Using the same vessel
diameters in all simulations, we varied vessel lengths, so that for all ves-
sels in the network, the lengths equaled the product of λ (which is fixed
for a given network) and the vessel diameter. We focused on λ-values in
the range measured in our tumors. We chose a synthetic network so that
only λ-related effects (and not other morphological network characteris-
tics) contributed to hemoconcentration/hemodilution. In future work, we
will investigate the combined effect on tissue oxygenation of the HS model
with memory effects and other tumor vascular characteristics.
Blood flow and HS.
Network flow problem. Tissue oxygenation depends on the hematocrit
distribution in the vessel network perfusing the tissue. The hematocrit dis-
tribution depends on the blood-flow rates. These rates are determined by
analogy with Ohm’s law for electric circuits, with the resistance to flow
depending on the local hematocrit via the Fahraeus–Lindquist effect (for
details, see SI Appendix and ref. 53). The flow rates and hematocrit are cou-
pled. We impose conservation of RBCs at all network nodes.* An HS rule
must then be imposed at all diverging bifurcations.
HS model without memory effects. The empirical HS model proposed by
Pries et al. (11, 54) states that the volume fraction of RBCs entering a par-
ticular branch FQE depends on the fraction of the total blood flow entering
that branch FQB as follows:
logit(FQE) = A + B logit
(
FQB−X0
1− 2X0
)
, [1]
*
∑
i
Q̃iHi = 0, where we sum over all vessels i meeting at a given node with hematocrit
Hi and signed flow rates Q̃i (of magnitude Qi).
where logit(x) = ln (x/(1− x)), B serves as a fitting parameter for the
nonlinear relationship between FQE and FQB, and A introduces asym-
metry between the child branches (note that for an equal flow split
FQB = 0.5, A 6= 0 yields uneven splitting of hematocrit). Finally, X0 is
the minimum flow fraction needed for RBCs to enter a particular
branch (for lower-flow fractions, no RBCs will enter)†; the term (1− 2X0)
reflects the fact that the CFL exists in both child vessels (SI Appendix,
Fig. S8A).
HS model with memory effects. We account for the effects of CFL
disruption and recovery by modifying the parameters A and X0 (as already
observed in ref. 11). For simplicity, and in the absence of suitable data,
we assume that the parameter B is the same in both child branches.
If X0,f (Af ) and X0,u (Au) denote the values of X0 (A) in the favorable
and unfavorable child branches (Fig. 3E), then our model of HS can be
written as:
logit(FQE,f ) = Af + B logit
(
FQB,f −X0,f
1−X0,u−X0,f
)
, [2]
where subscripts f and u relate to favorable and unfavorable branches,
respectively (see SI Appendix, Fig. S8A for a graphical depiction). It is pos-
sible to rewrite Eq. 2 in terms of the suspension flow rates Q≡QB and
hematocrit levels H of the favorable f , unfavorable u, and parent P vessels
as (for details, see SI Appendix):
Hf
Hu
= eAf
(
Qf −X0,f QP
Qu−X0,uQP
)B Qu
Qf
. [3]
This formulation of our HS model facilitates comparison with other HS mod-
els (40, 41, 55). Functional forms for Af , X0,f and X0,u are based on our RBC
simulation results and the existing literature (SI Appendix). We used an iter-
ative scheme (as in ref. 40) to determine the flow rates and hematocrit in a
given network.
Calculating the tissue oxygen distribution. We embedded the vessel net-
work in a rectangular tissue domain. A steady-state reaction–diffusion
equation models the tissue oxygen distribution, with source terms at ves-
sel network locations proportional to the hematocrit there, and sink terms
proportional to the local oxygen concentration modeling oxygen consump-
tion by the tissue. This equation was solved numerically by using Microvessel
Chaste (see ref. 13 and SI Appendix for details). In order to highlight the
influence of HS on tissue oxygen, we focused on the central 25% of the
domain which is well-perfused and ignored the avascular corner regions (SI
Appendix, Fig. S5 A and B).
Data Availability. The source code for the RBC simulations is available at
http://ccs.chem.ucl.ac.uk/hemelb. The source code for the oxygen perfusion
simulations is available at https://github.com/jmsgrogan/MicrovesselChaste
and https://github.com/chaste/chaste. All other data supporting the find-
ings of this study are available within the paper, SI Appendix, and
Datasets S1–S4.
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